Class Commencement 2025-26 Apply Now Enquire Now
Home

Dr. Charu Gupta

Associate Professor

  • Dr. Charu Gupta is currently working as an Associate Professor in Department of Biomedical Sciences, School of Biosciences and Technology, Galgotias University. 
  • Here she is bearing additional responsibilities of the lab coordinator and the research coordinator of the Department. She is also the NAAC Cr.3 coordinator of whole school. 
  • After qualifying, NET and GATE fellowships, she did her PhD work in Institute of Genomics and Integrative Biology (CSIR), Delhi and received her PhD degree from Delhi University. 
  • Following her PhD she continued post-doctoral research in various esteemed national and international institutions like National Institute of Immunology, Food and Drug Administration (FDA), USA, Jamia Hamdard, etc. 
  • Her keen interest and scientific acumen in molecular parasitology and biomedical research, helped her earn various national and international awards and fellowships like the Oak Ridge Institute for Science and Education (ORISE) Fellowship for research at Centre for Biologics Evaluation and Research, Food and Drug Administration NIH Campus, Bethesda, USA; Fellows Award for Research Excellence (FARE) for research at Centre for Biologics Evaluation and Research, Food and Drug Administration NIH Campus, Bethesda, USA; N-PDF from DST-SERB and DST-WOSA Women Scientist Program. 
  • She has presented her research work at several international and national conferences in India and abroad. 
  • Since she has joined university in 2021, since then, she played a key role in the development of research lab for her department and is also the lab and research coordinator of the School. 
  • She has completed numerous courses/ FDP/ training/ workshops conducted by highly reputed organizations. 

Experience Overview

  • Teaching Experience: 3 years, 10 months
  • Post-doctoral Research Experience: 9 years, 6 months
  • PhD Research Experience: 5 years
  • Total Experience (post-PhD): 13 years, 3 months
  • Total Experience (post-M.Sc.): 18 years, 3 months

Post-Doctoral Experience

  1.  DST-SERB National Post-doctoral Fellow (Oct 2017 – March 2020)
    • Principal Investigator (PI) of the project at the Institute of Molecular Medicine, Jamia Hamdard
    • Duration: 2.5 years
  2.  Post-doctoral Fellow (Oct 2010 – Sept 2015)
    • Centre for Biologics Evaluation and Research, Food and Drug Administration, NIH, USA
    • Duration: 5 years
  3.  ILS Bioservices, Global Discovery Center (July 2009 – July 2010)
    • Duration: 1 year
  4.  National Institute of Immunology (Oct 2007 – Oct 2008)
    • Duration: 1 year

Teaching Experience

  1.  Associate Professor (May2025-Till date)
  2. Assistant Professor Grade II (Sept 2021 – April 2025)
    • Department of Biotechnology, School of Biosciences and Technology, Galgotias University
    • Duration: 3 years, 3 months
  3.  Guest Lecturer (Oct 2019 – April 2020)
    • Department of Rehabilitation Sciences, Jamia Hamdard
    • Duration: 6 months

PhD Research

  • Duration: 2002 – 2007 (5 years)
  • Institute: Institute of Genomics and Integrative Biology (IGIB), Delhi University
  • Thesis Title: “Genomic Studies of Rheumatoid Arthritis”
  • Supervisor: Prof. H. R. Das, Proteomics & Structural Biology Division

Education

  • Master of Science (Biotechnology): Banaras Hindu University (BHU), Varanasi, India (2001)
  • Bachelor of Science: Purvanchal University, India (1998)

Awards and Fellowships

  • DST-SERB National Post-doctoral Fellowship, India (2017-2020)
  • Fellows Award for Research Excellence (FARE), USA (2014)
  • ORISE Fellowship, FDA, NIH Campus, USA (2010-2015)
  • CSIR-UGC NET Junior Research Fellowship (2002-2004)
  • CSIR-UGC NET Senior Research Fellowship (2004-2007)
  • GATE Qualified, MHRD, Government of India (2002)

c

  • DST-SERBNational Post-doctoral Fellowship: The Institute of Molecular Medicine, Jamia Hamdard, New Delhi. (Approved in Oct 2017) For 2 years, grant amount 19.2 lakhs.
  • DST-WOSAWomen Scientist Program: (Approved in Dec 2021) For 3 years, grant amount 33 lakhs Status: Not availed.
  • Seed grant proposal,Galgotias University (Approved in Sept 2021) For 1 years, grant amount 1 lakh. 

Publications

  1. Aptamers: Having diverse roles as a diagnostic tool and therapeutic agent for Infectious Disease. Neha Bhandari, Angamuthu Selvapandiyan, Charu Gupta*. Manuscript under preparation. *Corresponding Author.
  2. Sahu, D.*, Gupta, C.*, Yennamalli, R.M. et al. Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity. Scientific Reports 14, 12935 (2024). * Shared first authorship. https://doi.org/10.1038/s41598-024-63790-6 ISSN: 2045-2322 PMID: 38839973 Impact Factor: 4.3. 
  3. Heart valve treatment in rheumatic heart disease and plausible role of stem cell therapy. Vanshika Parmar#, Emon Kalyan Das#, Charu Gupta, Neha Sharma. KMICS Journal of Sciences (2023) 1, 01-14. https://doi.org/10.62011/kmicsjs.2023.1.1.3
  4. Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery. Fernanda Fortes de Araujo, Rana Nagarkatti, Charu Gupta, Ana Paula Marino and Alain Debrabant PLOS Neglected Tropical Diseases 2015, 9 (1): e3451. doi:10.1371/journal.pntd.0003451 ISSN:1935-2735 PMID: 25569299 Impact Factor: 3.83
  5. Aptamer based, non-PCR non-serological, detection of chagas disease biomarkers in Trypanosomacruzi infected mice. Rana Nagarkatti, Fernanda Fortes de Araujo, Charu Gupta and Alain Debrabant. PLOS Neglected Tropical Diseases 2014; 8 (1): e2650. doi:10.1371/journal.pntd.0002650 ISSN:1935-2735 PMID: 24454974 Impact Factor: 3.83
  6. Expression of TNF-α and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients. Raghav SK, Gupta B, Agrawal C, Chaturvedi VP and Das HR. Mediat. Inflamma. 2006; 2006(3): 1-5. 

doi: 10.1155/MI/2006/12682 ISSN: 1466-1861PMID: 16951485 Impact Factor: 3.23

  1. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance. Gupta B, Raghav SK, Agrawal C, Das RH, Chaturvedi VP and Das HR. J. Autoimmunity, 2006; 27 (2), 125-133. 

doi:10.1016/j.jaut.2006.07.002 ISSN: 0896-8411PMID: 16904869 Impact Factor: 7.64

  1. Altered expression and glycosylation of plasma proteins in rheumatoid arthritis. Raghav SK, Gupta B, Agrawal C, Saroha A, Das RH., Chaturvedi VP and Das HR. Glycocon. J. 2006; 23: 169-175. doi: 10.1007/s10719-006-7922-6 ISSN:0282-0080PMID: 16691500Impact Factor: 2.18
  2. Anti-inflammatory effect of Ruta graveolens L. in murine macrophage cells. Raghav SK, Gupta B, Agrawal C, Goswami K, Das HR. J Ethnopharmacol. 2006; 104(1-2):234-239. 

doi: 10.1016/j.jep.2005.09.008 ISSN: 0378-8741PMID: 16207519 Impact Factor: 2.98

  1. Association of mannose-binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples. Gupta B, Agrawal C, Raghav SK, Das SK, Das RH, Chaturvedi VP, Das HR. J. Hum. Genet. 2005; 50: 583–591. 

doi: 10.1007/s10038-005-0299-8 ISSN:1434-5161 PMID: 16220211Impact Factor: 2.47

  1. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Agrawal C, Raghav SK, Gupta B, Das RH, Chaturvedi VP, Goswami K, Das HR. Arch. Med. Res. 2005; 36 (5):555-9. 

doi:10.1016/j.arcmed.2005.03.035 ISSN:0188-4409 PMID: 16099338Impact Factor: 2.72

Book Chapter

  1. Factors Affecting Leishmania Infection in Sand Fly. Shital, Charu Gupta, Anuja Krishnan, Angamuthu Selvapandiyan. In book: Challenges and Solutions against Visceral Leishmaniasis. pp 63–79 doi: 10.1007/978-981-99-6999-9_4. ISBN: 978-981-99-6998-2

Patents

  1. AI-Driven Predictive Model for Early Detection and Management of acute febrile illness. Kaushalendra Kumar, Ranjana Patnaik, Neha Sharma, Charu Gupta, Anil Kumar Shrivastava, Hema Kumari. Application Number: 202311055705. Publication date- 20/08/2023
  2. AI-Driven Predictive Model for Early Detection and Management of acute Gastrointestinal Disorders Associated with Fever Hema Kumari, Gaurav Kumar, Charu Gupta, Neha Sharma, Nabya Nehal, Kaushalendra Kumar. Application Number: 202311056508. Publication date- 23/08/2023
  3. A disease diagnosis using spectroscopy and machine learning system. Shagun Jain, Dr. Charu Gupta, Lavi Tyagi, Surendra Singh Chauhan, Abhishek Sharma, Shriyansh Srivastava, Dr. Medhavi Malik. Application No. 202211019293, Indian Patent, Publication date- 8/04/2022.
  4. Method for the diagnosis of rheumatoid arthritis. Hasi Das, Bhawna Gupta, Sunil Kumar Raghav, Kalyan Goswami, Charu Agrawal and Rakha Hari Das. IPC8 Class: AG01N3353FI, US Patent 7763436, 2010/7/27.
  5. Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis. Hasi Das, Bhawna Gupta, Sunil Kumar Raghav, Kalyan Goswami, Charu Agrawal and Rakha Hari Das. US Patent App. 11/281,243, 2006/6/29.